RYAN WIYGUL: Open Payments
NPI 1174807135 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 18 payments from 7 companies in 2025. Trend: 2023 $359 · 2024 $187 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $198 |
| Boston Scientific Corporation | 2 | $63 |
| Astellas Pharma US Inc | 2 | $37 |
| Amgen Inc. | 2 | $31 |
| Acella Pharmaceuticals, LLC | 2 | $30 |
| Novo Nordisk Inc | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: QULIPTA, UBRELVY, WATCHMAN FLX, Veozah, EVENITY, NP Thyroid 60, Kerendia, VRAYLAR.
Industry payments across MS — which companies pay providers there.
